TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice
Brain, Behavior, and Immunity · 2024
DOI: 10.1016/j.bbi.2024.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024. Verfasst von Youbin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Program in Neuroscience, Seoul National University, Seoul 08826, Republic of Korea; Zilkha Neurogenetic Institute, Keck School of M…. Hauptthemen laut MEDLINE: Alzheimer Disease, Immunotherapy, Memory Disorders, Microglia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In Alzheimer's disease, chronic neuroinflammation is accompanied by amyloid and tau pathologies. Especially, aberrant microglial activation is known to precede the regional tau pathology development, but the mechanisms how microglia affect tau spread remain largely unknown. Here, we found that toll-like receptor 2 (TLR2) in microglia recognizes oligomeric tau as a pathogenic ligand and induces inflammatory responses. Knockout of TLR2 reduced tau pathology and microglial activation in rTg4510 tau transgenic mice. Treatment of oligomeric tau induced TLR2 activation and increased inflammatory responses in microglial cells. TLR2 further mediated the tau-induced microglial activation and promoted tau uptake into neurons in neuron-microglia co-culture system and in mouse hippocampus after intracranial tau injection. Importantly, treatment with anti-TLR2 monoclonal antibody Tomaralimab blocked TLR2 activation and inflammatory responses in a dose-dependent manner, and significantly reduced tau spread and memory loss in rTg4510 mice. These results suggest that TLR2 plays a crucial role in tau spread by causing aberrant microglial activation in response to pathological tau, and blocking TLR2 with immunotherapy may ameliorate tau pathogenesis in Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Program in Neuroscience, Seoul National University, Seoul 08826, Republic of Korea; Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
- School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea.
- Interdisciplinary Program in Neuroscience, Seoul National University, Seoul 08826, Republic of Korea; School of Biological Sciences, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: ykjung@…
Zitieren
APA
Kim, Y., Ryu, S. H., Hyun, J., Cho, Y. S., & Jung, Y. K. (2024). TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.08.002
Vancouver
Kim Y, Ryu SH, Hyun J, Cho YS, Jung YK. TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice. Brain, Behavior, and Immunity. 2024. doi:10.1016/j.bbi.2024.08.002
BibTeX
@article{Kim2024,
author = {Kim, Youbin and Ryu, Shin-Hyeon and Hyun, Junho and Cho, Young-Sin and Jung, Yong-Keun},
title = {TLR2 immunotherapy suppresses neuroinflammation, tau spread, and memory loss in rTg4510 mice},
journal = {Brain, Behavior, and Immunity},
year = {2024},
doi = {10.1016/j.bbi.2024.08.002}
}
EUVIMED